Thursday's NASDAQ Winners: KONG, SPWR, PAAS, HZNP

New York, NY - May 18, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Thursday, May 17. The Nasdaq Composite fell another 60.35 (-2.10%) to close at the session’s low of 2,813.69.

KongZhong Corporation (ADR) (NASDAQ:KONG) gained 12.33% to $6.65 in the previous trading session after the company reported first quarter net income of $6.9 million or $0.16 per American Depositary Share, or ADS, as compared to a net loss of $456,000 or $0.01 per ADS in the same period last year. Non-GAAP net income for the quarter was $8.7 million or $0.21 per ADS. Revenues for the quarter rose 12% to $43.8 million from $40.1 million a year ago.
Looking forward, the company expects second quarter net profit in the range of $6.5 million-$7.5 million, non-GAAP net profit in the range of $9 million-$10 million and revenues in the range of $49 million-$50 million.
Solar stock SunPower Corporation (NASDAQ:SPWR) shares jumped 10.04% to end at $5.59. On May 15, 2012, Scottsdale Unified School District and SunPower Corp. celebrated the installation of 5.5 megawatts of high efficiency SunPower solar power systems at 11 District schools. The systems are expected to reduce the District's electricity costs by $25 million over the next 25 years.
Pan American Silver Corp. (USA) (NASDAQ:PAAS) gained 7.65% to close at $16.04. The company's first-quarter profit fell 46% as expenses tied to the acquisition of a Mexican gold and silver operation masked a jump in revenue. The company posted a first quarter profit of $50.2 million, or $0.47 a share, as compared to $92.7 million, or $0.86 a share, a year earlier. Adjusted earnings fell to $0.58 a share. Revenue jumped 20% to $228.8 million, primarily on higher realized precious metals prices. Analysts expected a $0.46 a share profit with $230 million of revenue.
Horizon Pharma Inc (NASDAQ:HZNP) added 7.07% without any official news. The 52-week trading range for the stock is $3.05 - $9.34. Horizon Pharma, Inc. is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Recently, the company released its first-quarter financial results. For the first quarter ended March 31, 2012, the company reported net sales of $2.5 million, as compared with $1.8 million reported for the same period in the previous year. The company's net loss for the quarter was $23.7 million, or $0.98 per share, compared with $7.7 million, or $5.13 per share reported for the same period in the previous year.
Get Free investor news and stock alerts at Investorideas.com
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks Join: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
From time to time Investorideas.com buys shares in companies it features. As a policy, Investorideas.com does not short stocks
www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com